Refreshing results…
YES1 Is a Druggable Oncogenic Target in SCLC
UploadDSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
Download from rupress.orgTargeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Download from doi.orgYES1: A Novel Therapeutic Target and Biomarker in Cancer
Download from aacrjournals.orgCancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
Download from doi.orgMissing publications? Search for publications with a matching author name.